Ryu KS - Search Results

1

Human secreted frizzled-related protein is down-regulated and induces apoptosis in human cervical cancer.

Ko J, Ryu KS, Lee YH, Na DS, Kim YS, Oh YM, Kim IS, Kim JW. Ko J, et al. Among authors: ryu ks. Exp Cell Res. 2002 Nov 1;280(2):280-7. doi: 10.1006/excr.2002.5649. Exp Cell Res. 2002. PMID: 12413893

2

Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.

Ryu KS, Lee YS, Kim BK, Park YG, Kim YW, Hur SY, Kim TE, Kim IK, Kim JW. Ryu KS, et al. Exp Mol Med. 2001 Sep 30;33(3):136-44. doi: 10.1038/emm.2001.24. Exp Mol Med. 2001. PMID: 11642549

3

Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer.

Ryu KS, Kim JH, Ko HS, Kim JW, Ahn WS, Park YG, Kim SJ, Lee JM. Ryu KS, et al. Gynecol Oncol. 2004 Aug;94(2):325-32. doi: 10.1016/j.ygyno.2004.05.044. Gynecol Oncol. 2004. PMID: 15297169

4

Alterations of HLA class I and class II antigen expressions in borderline, invasive and metastatic ovarian cancers.

Le YS, Kim TE, Kim BK, Park YG, Kim GM, Jee SB, Ryu KS, Kim IK, Kim JW. Le YS, et al. Among authors: ryu ks. Exp Mol Med. 2002 Mar 31;34(1):18-26. doi: 10.1038/emm.2002.3. Exp Mol Med. 2002. PMID: 11989974

5

Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer.

Song JY, Jo HH, Kim MR, Lew YO, Ryu KS, Cha JH, Kang CS, Donahoe PK, MacLaughlin DT, Kim JH. Song JY, et al. Among authors: ryu ks. Int J Oncol. 2012 Jun;40(6):2013-21. doi: 10.3892/ijo.2012.1370. Epub 2012 Feb 14. Int J Oncol. 2012. PMID: 22344630 Free PMC article.

6

Identification of characteristic molecular signature of Müllerian inhibiting substance in human HPV-related cervical cancer cells.

Hwang SJ, Suh MJ, Yoon JH, Kim MR, Ryu KS, Nam SW, Donahoe PK, Maclaughlin DT, Kim JH. Hwang SJ, et al. Among authors: ryu ks. Int J Oncol. 2011 Oct;39(4):811-20. doi: 10.3892/ijo.2011.1042. Epub 2011 May 13. Int J Oncol. 2011. PMID: 21573503 Free PMC article.

7

Identification of large-scale characteristic genes of Müllerian inhibiting substance in human ovarian cancer cells.

Nam SW, Jo YS, Eun JW, Song JY, Ryu KS, Lee JY, Lee JM, Maclaughlin DT, Kim JH. Nam SW, et al. Among authors: ryu ks. Int J Mol Med. 2009 May;23(5):589-96. doi: 10.3892/ijmm_00000168. Int J Mol Med. 2009. PMID: 19360316

8

The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia.

Song JY, Chen KY, Kim SY, Kim MR, Ryu KS, Cha JH, Kang CS, MacLaughlin DT, Kim JH. Song JY, et al. Among authors: ryu ks. Int J Oncol. 2009 Jun;34(6):1583-91. doi: 10.3892/ijo_00000288. Int J Oncol. 2009. PMID: 19424576

9

The prognostic impact of duration of anemia during chemotherapy in advanced epithelial ovarian cancer.

Kim JH, Lee JM, Ryu KS, Lee YS, Park YG, Hur SY, Lee KH, Lee SH. Kim JH, et al. Among authors: ryu ks. Oncologist. 2011;16(8):1154-61. doi: 10.1634/theoncologist.2010-0236. Epub 2011 Jun 24. Oncologist. 2011. PMID: 21705663 Free PMC article.

10

Human papillomavirus 16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in 15-25 years old healthy Korean women.

Kim SC, Song YS, Kim YT, Kim YT, Ryu KS, Gunapalaiah B, Bi D, Bock HL, Park JS. Kim SC, et al. Among authors: ryu ks. J Gynecol Oncol. 2011 Jun 30;22(2):67-75. doi: 10.3802/jgo.2011.22.2.67. J Gynecol Oncol. 2011. PMID: 21860731 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters